199169 Racial and Ethnic disparities in Mental Health Care Utilization

Tuesday, November 10, 2009

Jie Chen , Department of Political Science, Economics, and Philosophy, College of Staten Island/City University of New York, Staten Island, NY
This study investigates factors associated with the racial and ethnic disparities in antidepressant drug use, physician visits, and psychotherapy utilization. This study seeks to determine the extent to which disparities reflect differences in observable population characteristics versus heterogeneity across racial and ethnic groups. Among the population characteristics, I am interested in identifying which factors are most important in accounting for racial and ethnic disparities in these outcomes. Blinder-Oaxaca decomposition techniques are employed to determine the extent to which disparities reflect differences in observable population characteristics versus unobserved heterogeneity across racial and ethnic groups.

Results show that Caucasians have the highest antidepressant drug utilization, doctor visits and psychotherapy visits. Differences in observable characteristics explain most of the ethnic differences in these outcomes, but not racial difference. Among the observed characteristics, language and access to health care facilities are the most important factors to explain the disparities.

Learning Objectives:
To investigate and quantify factors associated with the racial and ethnic disparities in antidepressant drug use, physician visits, and psychotherapy utilization.

Keywords: Mental Health Care, Utilization

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a health economics. I received my PhD degree in Economics from SUNY at Stony Brook. My research interets include pharmaceutical pricing, racial and ethnic health disparities, and mental health. Mt publications are the following: Jie Chen and John Rizzo. “Racial and Ethnic Disparities in Antidepressant Drug Use”. Journal of Mental Health Policy and Economics (2008), 11: 155-165. Jie Chen and John Rizzo. “Who Pays for Drug Quality?” Forthcoming: Eastern Economic Journal (2009).“Urban-Rural Health Disparities in China: A Longitudinal Study”. re-submitted “Entry Pricing and Product Quality: The Case of Antidepressant Drugs”.re-submitted.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.